Cite
HARVARD Citation
Elkahloun, A. et al. (2016). An integrative genome-wide transcriptome reveals that candesartan is neuroprotective and a candidate therapeutic for Alzheimer's disease. Alzheimer's research & therapy. 8 (1), pp. 1-18. [Online].